Harel Insurance Investments and Financial Services reports record second quarter 2026 results; comprehensive income up 30% to NIS 1.024 billion, ROE 37%

Harel Insurance Investments reported 2Q26 comprehensive income after tax of NIS 1.024B (+30% YoY) and ROE of 37%, with core profits after tax rising 17% to NIS 637M. For 1H26, comprehensive income after tax increased 19% to NIS 1.59B (ROE 27%), supported by a 68% jump in core profits in asset management/credit/equity alongside AUM growth to NIS 638B (+10% vs YE). The company highlighted CSM growth: total CSM reached NIS 17.7B and CSM new business rose 23% to NIS 992M. Harel also announced a shift to quarterly distributions and declared a NIS 400M dividend, with dividends and buybacks totaling ~NIS 1.5B since the beginning of the year.

Analysis

This reads as a higher-quality compounding story: fee-linked asset growth plus rising capital returns should matter more than the headline earnings beat. The key mechanism is operating leverage in asset management and fee-bearing balances, which tends to re-rate insurers when investors believe AUM can compound faster than claims inflation and credit losses. For HAHRF, the market may still be underpricing how much of current profitability is becoming recurring rather than cyclical.

Second-order, the sharper dividend cadence is likely to pull in income-focused local capital and support the stock on pullbacks, but it also raises the bar for sustaining growth without sacrificing solvency optionality. The credit book is the cleaner near-term swing factor: if property finance and SME lending stay benign, earnings power can surprise to the upside over the next 1-3 quarters; if delinquencies or funding spreads widen, that leverage reverses quickly. The 6-18 month question is whether investment income can keep masking a potentially softer underwriting environment.

Contrarian view: consensus may be extrapolating investment gains into a permanent ROE regime. If local equities or bond markets cool, ROE can compress faster than the market expects because the earnings mix still has a meaningful mark-to-market component. The move is not obviously overdone, but the better trade is to own the compounding engine and not chase the most cyclical line items; a growth slowdown in AUM or a credit-quality miss would be the clean falsifier.

Key Decisions for Investors

• Go long HAHRF on any post-print consolidation, targeting a 3-6 month hold; thesis is multiple support from recurring fee growth and more frequent capital return. Falsify if AUM growth decelerates materially or if quarterly credit losses start climbing.
• If liquidity allows, pair long HAHRF vs. a basket/ETF of Israeli financials to isolate insurer AUM/fee leverage from broader market beta; this should outperform if local markets stay constructive over the next 1-3 quarters.
• Use a stop-loss discipline around a sharp deterioration in investment income or a jump in claims/credit costs in the next quarterly update; those are the fastest paths to ROE compression.
• For traders, consider waiting for an intraday or 1-2 day post-earnings fade before initiating long exposure; the dividend policy change can create a better entry than chasing strength immediately.
• Set an alert on management commentary around credit underwriting and capital generation; if guidance implies slower portfolio growth or higher reserving, trim exposure because the stock’s premium case depends on those trends staying intact.